On 06.11.2019, the Central Goverment of PRC has accepted the HKSAR goverment’s proposal for the use of Hong Kong registered pharmaceutical products and common medical devices in designated Hong Kong-owned medical institutions in the Greater Bay Area.
As a facilitation measure for Hong Kong residents working and living in the Greater Bay Area to seek healthcare services, it will help attract local and multinational pharmaceutical, biomedical and health technology companies to apply for registration of new pharmaceutical products in Hong Kong and to introduce medical devices to Hong Kong with a view to expanding their businesses in Hong Kong and Mainland cities in the Greater Bay Area, benefiting patients in both places.
The Food and Health Bureau will be in discussion with relevant Mainland authorities on the implementation details, including the measure at the University of Hong Kong-Shenzhen Hospital on a pilot basis.
The medical institutes owned or managed by Hong Kong enterprises in the Greater Bay Area are listed in this table.
Learn more about how Cisema can support you with the Hong Kong MDACS registration.